Sigyn Therapeutics, Inc. (SIGY) › Cost of RevenueSigyn Therapeutics, Inc. (SIGY) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2017: $21.4K2018: $9.7K2019: $35.7K$35.7K2017Cost of Revenue (USD)2019Fiscal YearCost of RevenueChange YoY2019$35.7K+267.2%2018$9.7K-54.7%2017$21.4K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share